Histone lysine demethylases in breast cancer

Critical Reviews in Oncology/Hematology

Volumn 86, Issue 2, 2013, Pages 97-103

  Paolicchi, Elisa ^a,b   Crea, Francesco ^b   Farrar, William L ^c   Green, Jeffrey E ^a   Danesi, Romano ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PISA   (Italy)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Histone lysine demethylase; KDM3B; KDM5A; KDM6A; Polycomb

Indexed keywords

HISTONE DEMETHYLASE; HISTONE LYSINE DEMETHYLASE 3B; HISTONE LYSINE DEMETHYLASE 5A; HISTONE LYSINE DEMETHYLASE 6A; POLYCOMB GROUP PROTEIN; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER PROGNOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE INTERACTION; HISTONE LYSINE DEMETHYLASE 3B GENE; HISTONE LYSINE DEMETHYLASE 5A GENE; HISTONE LYSINE DEMETHYLASE 6A GENE; HUMAN; MOLECULAR PATHOLOGY; POLYCOMB GROUP GENE; PROTEIN EXPRESSION; REGULATOR GENE; REVIEW;

BREAST; BREAST NEOPLASMS; DATABASES, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEMETHYLASES; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; NUCLEAR PROTEINS; PROGNOSIS; RETINOBLASTOMA-BINDING PROTEIN 2;

EID: 84876072945     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2012.11.008     Document Type: Review

References (26)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA: A Cancer Journal for Clinicians 2012, 62(1):10-29.
2. Huang Y., Vasilatos S.N., Boric L., Shaw P.G., Davidson N.E. Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells. Breast Cancer Research and Treatment 2012, 131(3):777-789.
3. Rotili D., Mai A. Targeting histone demethylases: a new avenue for the fight against cancer. Genes Cancer 2011, 2(6):663-679.
4. Lim S., Janzer A., Becker A., et al. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 2010, 31(3):512-520.
5. Karytinos A., Forneris F., Profumo A., et al. A novel mammalian flavin-dependent histone demethylase. Journal of Biological Chemistry 2009, 284(26):17775-17782.
6. Bradley C., van der Meer R., Roodi N., et al. Carcinogen-induced histone alteration in normal human mammary epithelial cells. Carcinogenesis 2007, 28(10):2184-2192.
7. Hou H., Yu H. Structural insights into histone lysine demethylation. Current Opinion in Structural Biology 2010, 20(6):739-748.
8. Horton J.R., Upadhyay A.K., Qi H.H., Zhang X., Shi Y., Cheng X. Enzymatic and structural insights for substrate specificity of a family of jumonji histone lysine demethylases. Nature Structural & Molecular Biology 2010, 17(1):38-43.
9. Tsukada Y., Fang J., Erdjument-Bromage H., et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 2006, 439(7078):811-816.
10. Wolf S.S., Patchev V.K., Obendorf M. A novel variant of the putative demethylase gene, s-JMJD1C, is a coactivator of the AR. Archives of Biochemistry and Biophysics 2007, 460(1):56-66.
11. Li B.X., Zhang M.C., Luo C.L., et al. Effects of RNA interference-mediated gene silencing of JMJD2A on human breast cancer cell line MDA-MB-231 in vitro. Journal of Experimental and Clinical Cancer Research 2011, 30:90.
12. Kawazu M., Saso K., Tong K.I., et al. Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development. PLoS ONE 2011, 6(3):e17830.
13. Catchpole S., Spencer-Dene B., Hall D., et al. PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells. International Journal of Oncology 2011, 38(5):1267-1277.
14. Rhodes D.R., Yu J., Shanker K., et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. AM Neoplasia 2004, 6(1):1-6.
15. Ringnér M., Fredlund E., Häkkinen J., Borg Å., Staaf J. GOBO: gene expression-based outcome for breast cancer online. PLoS ONE 2011, 6(3):e17911.
16. Hu Z., Gomes I., Horrigan S.K., et al. A novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31. Oncogene 2001, 20(47):6946-6954.
17. Benevolenskaya E.V., Murray H.L., Branton P., Young R.A., Kaelin W.G. Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Molecular Cell 2005, 18(6):623-635.
18. Pasini D., Hansen K.H., Christensen J., Agger K., Cloos P.A., Helin K. Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2. Genes and Development 2008, 22(10):1345-1355.
19. Secombe J., Eisenman R.N. The function and regulation of the JARID1 family of histone H3 lysine 4 demethylases: the Myc connection. Cell Cycle 2007, 6(11):1324-1328.
20. Liefke R., Oswald F., Alvarado C., et al. Histone demethylase KDM5A is an integral part of the core Notch-RBP-J repressor complex. Genes and Development 2010, 24(6):590-601.
21. Crea F., Danesi R., Farrar W.L. Cancer stem cell epigenetics and chemoresistance. Epigenomics 2009, 1(1):63-79.
22. Zhou W., Chen H., Zhang L. The PcG protein hPc2 interacts with the N-terminus of histone demethylase JARID1B and acts as a transcriptional co-repressor. BMB Reports 2009, 42(3):154-159.
23. Evan G. Cancer. Taking a back door to target Myc. Science 2012, 335(6066):293-294.
24. Kopan R., Ilagan M.X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009, 137(2):216-233.
25. Agger K., Cloos P.A., Christensen J., et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 2007, 449(7163):731-734.
26. Cloos P.A., Christensen J., Agger K., Helin K. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes and Development 2008, 22(9):1115-1140.